Stryker Corporation

$281.17$-4.05 (-1.42%)
Last updated on --.

Stryker Corporation price

24 Hours-1.42%-$4.050
30 days-8.79%-$26.63
60 days-16.52%-$56.02
90 days-13.41%-$43.84

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Stock ticker
SYK
Company
Stryker Corporation
Industry
Healthcare
Category
US
Stock split / reverse split
12
Launch date
Mar 17, 1980
Listed exchange
NYSE

Financials

Q2 FY2026 Earnings
Report period: Apr 1, 2026 – Jun 30, 2026

Summary: SYK reported Revenue of 6.59B (+9.42%), meeting expectations; EPS of 3.69 (+17.89%), beating expectations.

Revenue (USD)Met6.59B+9.41%6.58B+10.83%9.66M+0.14%
EPS (USD)Beat3.69+17.89%3.49+13.68%0.20+5.73%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
2.292.222.201.933.30
+7.00%+2.77%+56.02%+14.20%+44.10%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
46.33B47.06B47.84B46.29B47.93B
25.14B25.27B25.42B23.31B23.94B
54.26%53.70%53.13%50.35%49.95%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
1.11B1.54B2.14B581.00M1.26B
+75.51%+4.47%+10.97%+132.40%+13.50%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.7.14%
VANGUARD CAPITAL MANAGEMENT LLC5.87%
John W. Brown5.23%
JPMORGAN CHASE & CO4.50%
STATE STREET CORP4.05%
Others73.18%
Institutions
% Owned80.93%+2.76%
Shares held309.92M+10.59M
Institutions2,333-33
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.7.14%-187.31K
VANGUARD CAPITAL MANAGEMENT LLC5.87%+153.66K
John W. Brown5.23%0.00
JPMORGAN CHASE & CO4.50%+1.66M
STATE STREET CORP4.05%+183.40K

Dividends

Dividends
Last ex-dividend: Sep 30, 2026 Cash dividend: 0.88 USD per share
Dividend yield TTM
1.25%
Payout ratio LFY
40.47%
Frequency
Quarterly
20222023202420252026
2.843.053.243.402.64
+1.15%+1.01%+0.89%+0.96%+1.27%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Mar 17, 1980
DateRatio
May 17, 20041 → 2
May 15, 20001 → 2
Jun 11, 19961 → 2
Jun 14, 19911 → 2
Jun 20, 19892 → 3
Jun 12, 19871 → 2
Sep 17, 19852 → 3
Nov 15, 19822 → 3
Nov 12, 19802 → 3

Stryker Corporation conversion tables

SYKSYK
USDUSD
0.5 SYK140.58 USD
1 SYK281.16 USD
5 SYK1,405.83 USD
10 SYK2,811.66 USD
USDUSD
SYKSYK
0.5 USD0.0017783 SYK
1 USD0.0035566 SYK
5 USD0.017783 SYK
10 USD0.035566 SYK

More to explore

FAQ

SYK is trading at $281.17, -1.42% over the last 24 hours. Track live moves on the price chart at the top of this page.

The SYK stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SYK is currently trading at $281.17, -1.42% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SYK price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SYK's P/E ratio is currently 29.07 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SYK; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SYK's historical range and other companies in the Healthcare sector.

Stryker Corporation's market cap is currently 107.54B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.